{"id":"W2730151298","doi":"10.3899/jrheum.170334","title":"Cost-effectiveness of Biological Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis: Implications for Clinical Practice","year":2017,"lang":"en","type":"letter","venue":"The Journal of Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatoid arthritis; Nice; Medical prescription; Antirheumatic drugs; Quality-adjusted life year; Cost effectiveness; Economic appraisal; Infliximab; Disease; Methotrexate; Quality of life (healthcare); Physical therapy; Antirheumatic Agents; Internal medicine; Intensive care medicine; Pharmacology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0106783,0.001529926,0.003325172,0.001413635,0.000553774,0.005847845,0.00273112,0.005676482,0.0101607],"category_scores_gemma":[0.09278928,0.0007537937,0.002204749,0.001825329,0.001521916,0.005137873,0.00154597,0.006006243,0.0005665835],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007705098,"about_ca_system_score_gemma":0.005161182,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008054144,"about_ca_topic_score_gemma":0.00719006,"domain_scores_codex":[0.9910584,0.007383619,0.0003596744,0.0003270522,0.0006376761,0.0002335839],"domain_scores_gemma":[0.9166916,0.07841884,0.002019159,0.0003769052,0.001616346,0.0008772397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002889307,0.001028025,0.00844789,0.006248359,0.003907387,0.0007498928,0.0004387438,0.4106404,0.0001355972,0.2057326,0.1099186,0.2498632],"study_design_scores_gemma":[0.002283427,0.0009123675,0.004999326,0.007670401,0.002471854,0.000722674,0.0006641313,0.2837602,0.0001530691,0.6555691,0.04050599,0.0002874256],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.03945491,0.2724757,0.07666083,0.5578078,0.008559445,0.0008005764,0.002079888,0.000135453,0.04202532],"genre_scores_gemma":[0.7613822,0.1296988,0.04261995,0.05066591,0.008409964,0.001076244,0.0008086222,0.0001849895,0.005153248],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.0106783,"threshold_uncertainty_score":0.0564729,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1526463682554329,"score_gpt":0.4458599793792608,"score_spread":0.2932136111238279,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}